Core Viewpoint - Proya has submitted its prospectus for a Hong Kong IPO, aiming to strengthen its market presence as a leading domestic cosmetics brand in China, with ambitions to rank among the top ten global cosmetics companies within the next decade [1][2]. Group 1: Company Overview - Proya, founded in 2003, has established itself as a significant player in the cosmetics industry, focusing on affordable beauty products primarily in lower-tier cities [3]. - The company has developed a brand matrix that includes its main brand Proya, as well as several other brands in makeup and personal care [3]. Group 2: Financial Performance - In 2022, Proya achieved a main business revenue of 6.385 billion yuan, with approximately 82.7% of this revenue coming from the Proya brand [4]. - The revenue growth rate for Proya has slowed, with a projected growth of 19.55% in 2024, down from 36.36% in the previous year [4][9]. - By the first half of 2025, Proya's revenue growth had dropped to 7.21%, significantly lower than the 37.9% growth in the same period the previous year [10]. Group 3: Brand Performance - The Proya brand continues to dominate revenue contributions, but its growth has stagnated, with a decline in revenue in the first half of 2025 compared to the previous year [4][10]. - Other brands under Proya, such as "Caitang," have also seen a decline in growth rates, with "Caitang" achieving a revenue of 1.191 billion yuan in 2024, a significant drop from its previous year's growth [5]. Group 4: Management Changes - Proya has experienced significant management changes, including the appointment of a new general manager, Hou Yameng, and the departure of key executives [14]. - The new management team is reportedly focused on expanding Proya's international presence, particularly in markets like Japan and Southeast Asia [15][16]. Group 5: International Expansion - Proya's international revenue remains minimal, accounting for only 1.3% of total revenue as of 2024, indicating that its overseas strategy is still in the exploratory phase [16]. - The company is considering acquisitions to enhance its international portfolio, particularly in the baby care, fragrance, and men's skincare segments [16].

Core Viewpoint - Proya has submitted its prospectus for a Hong Kong IPO, aiming to strengthen its presence in the cosmetics industry and achieve a position among the top ten global cosmetics companies within the next decade [2][3]. Company Overview - Founded in 2003 in Hangzhou, Proya has evolved into the fifth largest cosmetics group in China by retail sales as of 2024, being the only domestic brand among the top five [2]. - The company initially focused on the mass market, targeting third- and fourth-tier cities with a cost-effective strategy and has since expanded into e-commerce and multi-brand strategies [6]. Brand Performance - Proya's main brand continues to dominate its revenue, contributing approximately 80% of total income, with 2022 revenue from Proya at 52.64 billion yuan, accounting for 82.7% of total revenue [7]. - Despite the introduction of new brands, Proya's revenue growth has slowed, with the main brand's growth rate dropping from 36.36% in 2023 to 19.55% in 2024, and a negative growth in the first half of 2025 [7][10]. Financial Performance - In 2024, Proya's revenue reached 10.778 billion yuan, marking its first year surpassing the 10 billion yuan threshold, but growth rates have declined, with a 21.04% increase compared to the previous year [10]. - The company experienced a significant drop in revenue in the third quarter of 2025, with a year-on-year decline of 11.63% and a net profit decrease of 23.64% [11]. Pricing Trends - Average selling prices for Proya's products have decreased across all categories, with skincare products dropping by 22.19% year-on-year, and makeup products by 10.99% [12]. Management Changes - Proya has undergone significant management changes, including the appointment of a new general manager, which coincided with internal restructuring and the departure of key executives [15]. - The new management team is reportedly focused on international expansion, particularly in markets like Japan and Southeast Asia, with a current overseas revenue contribution of only 1.3% [16]. Strategic Initiatives - Proya is considering acquisitions to enhance its product offerings in areas such as children's products, fragrances, and men's skincare, with plans to leverage its Paris subsidiary for these initiatives [17].

Core Viewpoint - The light industry retail beauty sector is experiencing a weak recovery since 2025, with significant differentiation among sub-sectors and companies due to varying attributes and policy sensitivities. Domestic demand remains weak, while certain segments like trendy toys and beauty products show growth. International trade policies are slowing export growth. Looking ahead to 2026, government policies are expected to support consumption stabilization, but the marginal effects may diminish, leading to differentiated growth across sub-sectors [3]. Beauty and Aesthetic Medicine - The beauty sector is projected to achieve mid-single-digit growth in 2026, driven by domestic demand recovery. Ingredient upgrades and product innovations, particularly with emerging components like collagen and PDRN, are expected to enhance consumer purchasing needs. Competition is intensifying, leading to a concentration of market share among leading brands. The industry is anticipated to exhibit three trends: 1) National brands are moving towards globalization and group development; 2) Channel efficiency and operational capabilities are becoming more critical; 3) Market share is increasingly concentrated among top-performing brands [6]. - The aesthetic medicine sector is expected to see double-digit growth in 2026, supported by increased penetration rates and continuous market education. The supply side is becoming richer, stimulating demand. Two key trends are anticipated: 1) Midstream institutions are focusing on premium products and marketing capabilities; 2) Leading institutions are expanding through enhanced user operations and solutions [7]. Personal Care - The personal care sector is expected to benefit from increased online penetration and the rise of self-care demands, leading to a restructuring of the market. Product structures are anticipated to upgrade towards efficacy and premiumization. The rise of content e-commerce platforms is reshaping consumer access and marketing, providing opportunities for domestic brands to gain market share, particularly in segments like baby care, women's hygiene, and oral care [8]. Commercial New Retail - The retail sector is expected to continue its steady recovery into 2026, characterized by three trends: 1) Consumers are increasingly valuing cost-performance ratios, prompting businesses to focus on differentiated product offerings; 2) The clearance of outdated retail formats is nearing completion, with improved operational efficiency leading to profitability; 3) New consumption trends driven by emotional value are creating demand, supported by innovative product categories and localized operations [10]. Light Industry Manufacturing - The light manufacturing sector is facing weak overall demand but presents structural opportunities. Companies that can leverage industry transformation to develop new business models are expected to thrive. Key opportunities include: 1) Industry transformation driven by technological advancements, particularly in AI applications; 2) Export opportunities as companies enhance resilience through diversified global production and capitalize on improving overseas demand [13][14].

Core Viewpoint - The established domestic cosmetics brand, Chando, is preparing for an IPO in Hong Kong amid the rising trend of "national beauty brands" in the consumer market, but faces challenges such as unstable profitability and declining R&D investment [1][12]. Financial Performance - Chando's revenue for the years 2022 to 2025 (first half) is reported as 4.292 billion, 4.442 billion, 4.601 billion, and 2.448 billion respectively, with 90% of its revenue dependent on the single brand "Chando" [2]. - The net profit figures for the same period are 139 million, 302 million, 190 million, and 191 million, with the first half of 2025 already exceeding the full-year profit of 2024 [2]. R&D Investment - R&D expenditures have decreased over the years, with amounts of 120 million, 93.82 million, 91.21 million, and 42.38 million reported, leading to a declining R&D expense ratio from 2.8% in 2022 to 1.7% in the first half of 2025, which is significantly lower than peers [3][4]. Employee Structure - As of June 30, 2025, Chando has a total of 2,102 employees, with only 154 in R&D, making up 7.3% of the workforce, while administrative staff constitute 8.8% [5]. Consumer Complaints - Chando has received 1,144 complaints on the Black Cat Complaints platform, primarily related to issues such as price discrepancies, allergic reactions, and poor customer service [6][7]. - Complaints include specific cases of unfulfilled promises regarding price guarantees and missing items in orders, indicating potential issues in customer service and fulfillment [6][7]. Market Position and Strategy - The Chinese cosmetics market is the second largest globally, with a projected growth from 779.4 billion in 2019 to 934.6 billion by 2024, reflecting a compound annual growth rate of 3.7% [9]. - Chando's strategy appears conservative, with indications that it may not pursue aggressive expansion or acquisitions due to the associated risks and challenges [10][11][12].

Core Viewpoint - The well-known domestic beauty brand, Chando, has initiated its IPO process, marking a significant step towards its market expansion despite recent underwhelming performance in revenue growth and profitability [1][4]. Group 1: Financial Performance - In 2024, Chando reported a revenue of 4.601 billion yuan, reflecting a year-on-year growth of 3.58%, while its net profit decreased by nearly 40% to 190 million yuan [2][5]. - Chando's revenue is significantly lower compared to its competitors, with Proya and Shiseido achieving revenues of 10.778 billion yuan and 6.793 billion yuan respectively in 2024 [2][5]. - Chando's revenue in 2024 was approximately 80% of Beitaini's revenue, which reached 5.7 billion yuan [6]. Group 2: Online Channel Transformation - Chando's slow transition to online sales channels is a critical factor in its performance, with online sales accounting for less than 70% of its revenue, compared to over 80% for Proya [3][10]. - The online channel's contribution to Chando's revenue increased from 59.7% in 2022 to 68.8% in 2024, indicating a gradual but insufficient shift [10]. - In contrast, Proya's online revenue share surged from 70.01% in 2020 to 93.07% in 2023, showcasing a successful adaptation to market changes [8]. Group 3: Marketing and Brand Strategy - Chando has invested heavily in marketing, with total expenditures reaching 7.568 billion yuan from 2022 to 2024, which is significantly higher than the industry average [3][21]. - The marketing expense ratio for Chando was 59% in 2024, compared to an average of 47.78% for its peers, indicating a higher cost burden [21][23]. - Chando is focusing on launching new brands to drive growth, with the brand "Pofenyan" showing promising results, generating 121 million yuan in revenue in 2024, a growth of over 90% [20]. Group 4: Future Outlook - Chando plans to enhance its marketing efforts through collaborations with KOLs and increased advertising on major e-commerce and social media platforms [23]. - The company aims to open more offline flagship stores to strengthen its market presence, with new stores planned in major cities [13][16]. - The effectiveness of Chando's marketing investments and its ability to adapt to changing consumer preferences will be crucial for its future growth [23].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry [2]. Core Views - The cosmetics and medical beauty sector has shown stronger performance than the market, with the Shenwan Beauty Care Index declining by 2.5% from October 10 to October 17, 2025, which is better than the overall market performance [4][5]. - The Tmall Double 11 event has seen significant success for domestic brands, with brands like Maogeping experiencing high demand and sold-out products [10]. - The overall performance for Q3 2025 is expected to meet expectations, with a continued upward trend into Q4, driven by promotional events [11][12]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector outperformed the market during the specified period, with the Shenwan Cosmetics Index down by 1.1%, which is 2.3 percentage points better than the Shenwan A Index [4][5]. - Key stocks in the sector included Jiaheng Jiahua (+35.0%), Yiyi Co. (+18.6%), and Yanjing Co. (+15.6%) [6]. Market Trends - The Tmall Double 11 event on October 15 attracted over 10 million viewers, with domestic brands like Maogeping experiencing supply shortages due to high demand [10]. - The overall sales performance is expected to improve in the coming weeks, particularly with the upcoming Douyin Double 11 event [10]. Q3 Performance Outlook - The demand for cosmetics remains robust, with retail sales growth in July and August outpacing the overall market [11]. - The total retail sales of cosmetics for the first eight months of 2025 reached 291.5 billion yuan, a year-on-year increase of 3.3% [11]. - Domestic brands are leveraging online channels effectively, with Han Shu achieving over 2 billion yuan in GMV in Q3 [12]. Company Highlights - Han Shu announced a global partnership with Wang Jiaer, enhancing its international presence and brand recognition [19][22]. - The report recommends focusing on companies with strong channel and brand matrices, such as Maogeping, Shanghai Jahwa, and Up Beauty [14]. E-commerce Data - The report highlights significant growth in e-commerce sales for various brands, with Han Shu achieving a 37% increase in GMV [15]. - The overall e-commerce landscape for domestic brands is expected to continue thriving, supported by promotional events and strategic partnerships [15][18]. Market Dynamics - The report notes that the Chinese skincare market is projected to reach 271.2 billion yuan in 2024, despite a slight decline in growth [26]. - Domestic brands are increasingly capturing market share, with a notable presence in the top ten rankings [26][27]. Investment Recommendations - The report suggests investing in companies with strong growth potential and robust product pipelines, particularly in the cosmetics and medical beauty sectors [14]. - Specific recommendations include Maogeping, Up Beauty, and Shanghai Jahwa for cosmetics, and Aimeike for medical beauty [14].

Core Viewpoint - The news highlights the IPO application of CHANDO, a well-established Chinese beauty brand, aiming to enter the Hong Kong stock market with a valuation exceeding 7.1 billion RMB, backed by significant investments from L'Oréal and other capital firms [3][5][6]. Company Overview - CHANDO has been in operation for 25 years and is now the third-largest domestic cosmetics group in China, with annual revenues exceeding 4.5 billion RMB [4][7]. - The company has a diverse brand portfolio, including CHANDO, Biorrier, MAYSU, SPRING SUNMER, and others, covering various product categories such as skincare, makeup, and personal care [7][8]. - The flagship brand, CHANDO, has consistently contributed over 94% of the company's total revenue from 2022 to 2025 [7][11]. Financial Performance - Revenue figures for CHANDO from 2022 to 2025 are projected to be 42.92 billion RMB, 44.42 billion RMB, and 46.01 billion RMB, with a significant increase in gross margin from 66.5% in 2022 to 70.1% in the first half of 2025 [7][11]. - The company has a registered membership of 37.7 million, with a repurchase rate of 32.4%, indicating a stable customer base [8]. Investment Backing - L'Oréal invested 442 million RMB and Cahua Capital invested 300 million RMB in CHANDO, holding 6.67% and 4.20% of shares, respectively, leading to a pre-IPO valuation exceeding 7.1 billion RMB [6][10]. Market Position and Challenges - The beauty industry in China is highly fragmented, with the top five domestic cosmetics groups holding only about 10.1% market share, indicating a low concentration [11]. - CHANDO's revenue growth rate of 3.6% for 2024 is significantly lower than competitors like Mao Geping and Lin Qingxuan, which have higher growth rates [11]. - The brand's international recognition and market share are limited, with a need to leverage L'Oréal's backing to expand overseas [11][12]. Industry Trends - The domestic beauty market is evolving, with Chinese brands capturing approximately 55.2% market share by 2024, reflecting a growing preference for local products among consumers [12]. - The competition is intensifying, with brands focusing on research and development, emphasizing patent acquisition and scientific investment [12].

Core Viewpoint - Natural Hall, a well-established Chinese cosmetics brand, has submitted its IPO application to the Hong Kong Stock Exchange, aiming for a valuation exceeding 7.1 billion RMB, backed by investments from major players like L'Oréal and China Capital [1][4]. Company Overview - Founded 25 years ago, Natural Hall has become the third-largest domestic cosmetics group in China, with annual revenues exceeding 4.5 billion RMB as of 2024 [3]. - The company has a diverse brand portfolio, including Natural Hall, Biorrier, MAYSU, Spring Summer, and GB, covering various product categories such as skincare, makeup, and personal care [5][6]. Financial Performance - Revenue figures for Natural Hall from 2022 to 2025 are projected as follows: 42.92 billion RMB in 2022, 44.42 billion RMB in 2023, and 46.01 billion RMB in 2024, with 24.48 billion RMB in the first half of 2025 [5]. - The gross profit margin has shown a steady increase, from 66.5% in 2022 to 70.1% in the first half of 2025 [5]. Investment Backing - The IPO is supported by significant investments from L'Oréal (442 million RMB) and China Capital (300 million RMB), which hold 6.67% and 4.20% of the company, respectively [4][5]. Market Position and Challenges - Natural Hall's market share is under pressure from competitors, with the top five domestic cosmetics groups holding only about 10.1% of the market share as of 2024 [11]. - The company faces challenges in revenue growth, with a projected growth rate of only 3.6% for 2024, significantly lower than competitors like Mao Ge Ping and Lin Qingxuan [11][12]. Brand Recognition and Customer Base - Natural Hall has a stable customer base, with 37.7 million registered members and a repurchase rate of 32.4% [7]. - The flagship brand, Natural Hall, consistently contributes over 94% of the company's total revenue from 2022 to 2025 [5][12]. Future Outlook - The IPO represents a strategic move for Natural Hall to strengthen its position in the competitive beauty market and potentially expand its presence in overseas markets, leveraging L'Oréal's endorsement [11][14]. - The company is entering a phase of heightened competition, with a focus on research and development becoming crucial for survival and growth in the evolving beauty industry [14].

Core Viewpoint - The recent IPO application by Naturando Global Holdings Limited marks a significant move in the Chinese beauty market, reflecting both the company's ambition to prove its strength in the capital market and the competitive pressures faced by mid-tier beauty brands in a saturated market [1][6]. Company Overview - Naturando, established 25 years ago, has submitted its IPO application to the Hong Kong Stock Exchange with a valuation exceeding 7.1 billion RMB, backed by investments from L'Oréal (442 million RMB) and Cahua Capital (300 million RMB) [1][2]. - The company has positioned itself as the third-largest domestic cosmetics group in China, with annual revenues exceeding 4.5 billion RMB [1][3]. Financial Performance - Naturando's revenue figures for 2022 to 2024 are reported as 42.92 billion RMB, 44.42 billion RMB, and 46.01 billion RMB, with a revenue of 24.48 billion RMB in the first half of 2025 [3]. - The gross profit margins have shown a steady increase, from 66.5% in 2022 to 70.1% in the first half of 2025 [3]. Brand Portfolio - The company has developed a diverse brand portfolio, including Naturando, Pofuyan, Chunsummer, Meisu, and Jichu, covering various categories such as skincare, makeup, personal care, men's grooming, and children's care [3]. - Naturando remains the most recognized brand, contributing over 94% of total revenue from 2022 to 2025 [3]. Shareholding Structure - The Zheng family, as the founders, have structured the shareholding to protect their interests, with a complex offshore holding setup ensuring control over the company [4][5]. Market Position and Competition - The beauty industry in China is highly fragmented, with the top five domestic cosmetics groups holding only about 10.1% market share, indicating low concentration [7]. - Naturando's revenue growth rate of 3.6% for 2024 is significantly lower than competitors like Mao Geping and Lin Qingxuan, highlighting the need for enhanced growth strategies [7]. Industry Trends - The domestic beauty market is experiencing a shift, with local brands capturing approximately 55.2% market share by 2024, indicating a growing preference for domestic products among consumers [8]. - The competition is intensifying, with brands engaging in a "scientific arms race" to enhance their research and development capabilities, which is crucial for capital investment [8].

Core Viewpoint - The company, Chando, is preparing for an IPO after 24 years in the beauty industry, marking a significant shift as it brings in external investors like L'Oréal and Cathay Capital for the first time [1][9]. Company Background - Chando was founded by Zheng Chunying in 2001, initially starting with two brands, Chando and Meisu, and gradually expanding into skincare, makeup, and maternal and infant care [5]. - The Zheng family maintains significant control over the company, with a combined stake of nearly 87% before the IPO [7]. Financial Performance - Revenue is projected to grow from 42.92 billion RMB in 2022 to 46.01 billion RMB in 2024, with 24.48 billion RMB reported in the first half of 2025 [13]. - The gross profit margin has been increasing, surpassing 70.1% in the first half of 2025 [13]. Research and Marketing Discrepancies - Research and development (R&D) spending from 2022 to June 2025 totaled 3.48 billion RMB, with the R&D expense ratio declining from 2.8% to 1.7%, while marketing expenses remained high at 54% to 59% [15]. - The company has faced challenges in adapting to consumer demands for ingredient transparency and efficacy, falling behind competitors like Winona and Proya [18]. Brand and Channel Dependency - Chando heavily relies on its single brand, which accounted for approximately 95% of its revenue from 2022 to the first half of 2025, with other brands contributing only 5% [20]. - The online sales ratio increased from 59.7% in 2022 to 68% in the first half of 2025, but still lags behind competitors like Proya, which has nearly 95% online sales [22]. Strategic Recommendations - The company needs to transform its offline channels from mere sales points to experiential zones, enhancing customer engagement through in-store experiences [26]. - Learning from competitors like Proya, which successfully integrates online live streaming with offline pop-up stores, could help Chando attract more traffic and improve customer experience [28].